IPO/Dividend
Dividend
Dividend yield for the recent three fiscal years
| Category | Term 23 | Term 22 | Term 21 | |
|---|---|---|---|---|
| Par Value per Share (KRW) | 500 | 500 | 500 | |
| Consolidated Net Income (KRW million) | 3,461 | 3,396 | 1,877 | |
| Separate Net Income (KRW million) | 3,992 | 3,875 | 1,671 | |
| Consolidated Earnings per Share (KRW) | 169 | 168 | 85 | |
| Total Cash Dividends (KRW million) | - | - | - | |
| Total Stock Dividends (KRW million) | - | - | - | |
| Consolidated Cash Dividend Payout Ratio(%) | - | - | - | |
| Cash dividend yield ratio (%) | Common stock | - | - | - |
| Preferred stock | - | - | - | |
| Stock dividend yield ratio (%) | Common stock | - | - | - |
| Preferred stock | - | - | - | |
| Cash dividends per share (won) | Common stock | - | - | - |
| Preferred stock | - | - | - | |
| Stock dividends per share (%) | Common stock | - | - | - |
| Preferred stock | - | - | - |
[As of December 31, 2025]
(16907) 15, Yonggu-daero 2469beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do (Bojeong-dong) Representational KIM YOUNKEUN
TEL +82-31-267-8458 FAX +82-31-260-9416 E-MAIL gcms.overseas@greencross.com
COPYRIGHT(C) GC MEDICAL SCIENCE CORP. ALL RIGHTS RESERVED.